U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
114361114361External Pancreatic Duct Stent After PancreaticoduodenectomyCompletedNo Results AvailablePancreatic FistulaProcedure: External pancreatic stenthttps://ClinicalTrials.gov/show/NCT01068886
114362114362Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)TerminatedNo Results AvailableHIV InfectionsDrug: lopinavir/ritonavir plus maravirochttps://ClinicalTrials.gov/show/NCT01068873
114363114363To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes TherapiesCompletedHas ResultsType 2 Diabetes Mellitus|Impaired Glucose ToleranceDrug: Canakinumab 150 mg|Drug: Placebo to Canakinumabhttps://ClinicalTrials.gov/show/NCT01068860
114364114364Drug Discrimination in Methadone-Maintained Humans Study 3CompletedNo Results AvailableDrug DependenceDrug: 2-4 of the drugs listed belowhttps://ClinicalTrials.gov/show/NCT01068847
114365114365Additional KIF6 Risk Offers Better Adherence to StatinsCompletedNo Results AvailableCardiovascular Diseases|DyslipidemiaGenetic: KIF6 genetic testhttps://ClinicalTrials.gov/show/NCT01068834
114366114366Trendelenburg's Slide Prevention StudyCompletedHas ResultsMisadventure During Surgical Operation|Postoperative ComplicationsOther: Gel pad|Other: Egg crate foam mattresshttps://ClinicalTrials.gov/show/NCT01068821
114367114367The Development of Allergic Rhinitis in Children Previously Diagnosed as Nonallergic RhinitisCompletedNo Results AvailableAllergic Rhinitis (Disorder)Procedure: skin prick testhttps://ClinicalTrials.gov/show/NCT01068808
114368114368Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy OutcomeActive, not recruitingNo Results AvailableFetal Demise|Fetal Growth Restriction|Preeclampsia|Abruptio Placentae|ThromboembolismDrug: enoxaparinhttps://ClinicalTrials.gov/show/NCT01068795
114369114369Study of Multiple Doses and Regimens of XL184 (Cabozantinib) in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseCompletedNo Results AvailableAstrocytic TumorsDrug: XL184https://ClinicalTrials.gov/show/NCT01068782
114370114370Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal TumorActive, not recruitingHas ResultsGastrointestinal Stromal TumorDrug: regorafenibhttps://ClinicalTrials.gov/show/NCT01068769
114371114371Effect of Rifampin on the Pharmacokinetics of Dapagliflozin in Healthy SubjectsTerminatedNo Results AvailableType 2 Diabetes MellitusDrug: Dapagliflozin|Drug: Rifampinhttps://ClinicalTrials.gov/show/NCT01068756
114372114372Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-AdministeredCompletedHas ResultsType 2 Diabetes MellitusDrug: saxagliptin|Drug: metformin|Drug: saxagliptin + metformin (FDC tablet)https://ClinicalTrials.gov/show/NCT01068743
114373114373Bioequivalence Study of 500 mg and 1000 mg Glucophage (Metformin) Tablets in Healthy SubjectsCompletedHas ResultsType 2 Diabetes MellitusDrug: metformin (Diabex)|Drug: metformin (Glucophageâ„¢)|Drug: metformin (Glucophageâ„¢)|Drug: metformin (Diabex)https://ClinicalTrials.gov/show/NCT01068730
114374114374Bioequivalence Study of 2.5-mg Saxagliptin and 500-mg Glucophage in Tablets and a Fixed-dose Combination Tablet in Healthy ParticipantsCompletedHas ResultsType 2 Diabetes MellitusDrug: Saxagliptin, 2.5 mg + Metformin, 500 mg (fasted state)|Drug: Saxagliptin, 2.5 mg /Metformin, 500 mg FDC (fasted state)|Drug: Saxagliptin, 2.5 mg + Metformin, 500 mg (fed state)|Drug: Saxagliptin, 2.5 mg /Metformin, 500 mg FDC (fed state)https://ClinicalTrials.gov/show/NCT01068717
114375114375Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDrug: BMS-690514|Drug: Lapatinib|Drug: Letrozolehttps://ClinicalTrials.gov/show/NCT01068704
114376114376Arterial Properties of Thoracic Aorta DiseaseRecruitingNo Results AvailableBlood PressureProcedure: Ambulatory blood pressure monitoring (to evaluate the level of blood pressure)https://ClinicalTrials.gov/show/NCT01068691
114377114377Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin degludec|Drug: insulin glarginehttps://ClinicalTrials.gov/show/NCT01068678
114378114378Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin degludec|Drug: insulin glarginehttps://ClinicalTrials.gov/show/NCT01068665
114379114379Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic DrugsCompletedHas ResultsDiabetes|Diabetes Mellitus, Type 2Drug: insulin detemir|Drug: insulin aspart|Drug: biphasic insulin aspart 30|Drug: metforminhttps://ClinicalTrials.gov/show/NCT01068652
114380114380An Observational Study on Treatment Compliance by Children Treated With Growth HormoneWithdrawnNo Results AvailableGrowth Hormone Disorder|Growth Hormone Deficiency in ChildrenBehavioral: No treatment givenhttps://ClinicalTrials.gov/show/NCT01068639
114381114381Rosuvastatin in Visceral AdiposityCompletedHas ResultsAbdominal ObesityDrug: Rosuvastatin|Drug: Placebo for rosuvastatinhttps://ClinicalTrials.gov/show/NCT01068626
114382114382Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: QAX028|Drug: QAX028|Drug: Tiotropium|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01068613
114383114383Comparison of Efficacy of Indacaterol Versus Placebo Over 12 WeeksCompletedHas ResultsChronic Obstructive Pulmonary DiseaseDrug: Indacaterol|Drug: Placebo to indacaterolhttps://ClinicalTrials.gov/show/NCT01068600
114384114384MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous ChemotherapyCompletedNo Results AvailableLung CancerDrug: MET/VEGFR2 inhibitor Foretinib|Drug: erlotinib hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01068587
114385114385Evaluation of the Basic Assessment of Severity of Illness in Children (BASIC) ScaleRecruitingNo Results AvailableAcute IllnessOther: BASIC Score (Observational)https://ClinicalTrials.gov/show/NCT01068574
114386114386Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis PigmentosaCompletedNo Results AvailableRetinitis PigmentosaBiological: intravitreal injection of autologous bone marrow stem cellshttps://ClinicalTrials.gov/show/NCT01068561
114387114387Reducing Length of Stay for Veterans Hospitalized With PneumoniaCompletedHas ResultsPneumoniaOther: reminderhttps://ClinicalTrials.gov/show/NCT01068548
114388114388Early Vascular Wall Changes by Magnetic Resonance Imaging (MRI) in Metabolic Syndrome Versus Metabolically Normal Pre-Menopausal Women: A Pilot StudyActive, not recruitingNo Results AvailableMetabolic Syndromehttps://ClinicalTrials.gov/show/NCT01068535
114389114389Study to Improve Outcomes for Survivors of Traumatic Brain Injury in Latin AmericaActive, not recruitingNo Results AvailableTraumatic Brain Injury|Brain InjuriesDevice: Parenchymal Intracranial pressure monitor|Other: Treatment based on clinical and imaging observationshttps://ClinicalTrials.gov/show/NCT01068522
114390114390Ovarian Cancer Vaccine for Patients in RemissionCompletedNo Results AvailableEpithelial Ovarian CancerBiological: MUC1 Dendritic Cell Vaccine (Cvac)https://ClinicalTrials.gov/show/NCT01068509

* Görseller ve İçerik tekif hakkına sahip olabilir